OMRON Ventures joins existing backers including abrdn, Environmental Technologies Fund, and Granpool Innovative Investments in backing the TechBio platform.
abrdn
Venture Capitalabrdn is an investment company that has become the largest external shareholder in Archax through its strategic backing.
Portfolio
2
companies
Portfolio companies

Eagle Genomics
Eagle Genomics develops an AI-augmented knowledge discovery platform for biological and microbiome data analysis.
Archax
Archax operates a regulated digital asset exchange, brokerage and custodian for institutional investors.
Team
Stephen Bird
CEO
Alistair Watson
Head of Strategy Innovation – Private Equity
Russel Barlow
Global Head of Alternatives
Recent investments
The funding round was led by abrdn with participation from international backers.
"We are extremely pleased to have been able to complete a round of this size during the turbulent crypto and traditional financial market conditions of the last few months. It is also fantastic to have such credible and strategic partner investors involved in the raise too – led by abrdn. We look forward to the next phase of the Archax journey as we scale up for launch and beyond with these partnerships in place."
The funding round was led by abrdn and will support platform development and international expansion.
"We are the pre-eminent platform business using next-generation graph technology and network science to drive the Bioeconomy. We are seeking to support our enterprise customers as they strive to achieve more sustainable and impact-orientated innovation outcomes. The current scale-up funding will enable us to accelerate the Bioeconomy through the digital reinvention of science."
abrdn takes a strategic stake in Archax to back its regulated digital securities exchange.
"Blockchain technologies are inevitably going to form a big part of the future of financial markets. There is the potential to offer greater transparency, greater speed and less trading friction by using these nascent digital technologies."